Down-regulation of the myoinositol transporter SMIT by JAK2

Cellular Physiology and Biochemistry

Volumn 30, Issue 6, 2012, Pages 1473-1480

  Hosseinzadeh, Zohreh ^a   Bhavsar, Shefalee K ^a   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Cell volume; Energy depletion; Inositol transport; Osmolyte

Indexed keywords

BREFELDIN A; COMPLEMENTARY RNA; INOSITOL; JANUS KINASE 2; MYOINOSITOL TRANSPORTER; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; UNCLASSIFIED DRUG;

ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME KINETICS; ENZYME STABILITY; NONHUMAN; OOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; VOLTAGE CLAMP; XENOPUS;

EID: 84870297400     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000343335     Document Type: Article

References (57)

1. Lopez AF, Hercus TR, Ekert P, Littler DR, Guthridge M, Thomas D, Ramshaw HS, Stomski F, Perugini M, D'Andrea R, Grimbaldeston M, Parker MW: Molecular basis of cytokine receptor activation. IUBMB Life 2010;62:509-518.
2. Noon-Song EN, Ahmed CM, Dabelic R, Canton J, Johnson HM: Controlling nuclear JAKs and STATs for specific gene activation by IFNgamma. Biochem Biophys Res Commun 2011;410:648-653.
3. Spivak JL: Narrative review: Thrombocytosis, polycythemia vera, and JAK2 mutations: The phenotypic mimicry of chronic myeloproliferation. Ann Intern Med 2010;152:300-306.
4. Morris DL, Rui L: Recent advances in understanding leptin signaling and leptin resistance. Am J Physiol Endocrinol Metab 2009;297:E1247-E1259.
5. Brooks AJ, Waters MJ: The growth hormone receptor: mechanism of activation and clinical implications. Nat Rev Endocrinol 2010;6:515-525.
6. Yang N, Jiang J, Deng L, Waters MJ, Wang X, Frank SJ: Growth hormone receptor targeting to lipid rafts requires extracellular subdomain 2. Biochem Biophys Res Commun 2010;391:414-418.
7. Baskin R, Majumder A, Sayeski PP: The recent medicinal chemistry development of Jak2 tyrosine kinase small molecule inhibitors. Curr Med Chem 2010;17:4551-4558.
8. Ho K, Valdez F, Garcia R, Tirado CA: JAK2 Translocations in hematological malignancies: Review of the literature. J Assoc Genet Technol 2010;36:107-109.
9. Oh ST, Gotlib J: JAK2 V617F and beyond: role of genetics and aberrant signaling in the pathogenesis of myeloproliferative neoplasms. Expert Rev Hematol 2010;3:323-337.
10. Pardanani A, Vannucchi AM, Passamonti F, Cervantes F, Barbui T, Tefferi A: JAK inhibitor therapy for myelofibrosis: critical assessment of value and limitations. Leukemia 2011;25:218-225.
11. Santos FP, Verstovsek S: JAK2 inhibitors: What's the true therapeutic potential? Blood Rev 2011;25:53-63.
12. Tefferi A: Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1. Leukemia 2010;24:1128-1138.
13. Mahfouz RA, Hoteit R, Salem Z, Bazarbachi A, Mugharbel A, Farhat F, Ziyadeh A, Ibrahim A, Taher A: JAK2 V617F Gene Mutation in the Laboratory Work-Up of Myeloproliferative Disorders: Experience of a Major Referral Center in Lebanon. Genet Test Mol Biomarkers 2011;15:263-265.
14. Shen XL, Wei W, Xu HL, Zhang MX, Qin XQ, Shi WZ, Jiang ZP, Chen YJ, Chen FP: JAK2V617F/STAT5 signaling pathway promotes cell proliferation through activation of Pituitary Tumor Transforming Gene 1 expression. Biochem Biophys Res Commun 2010;398:707-712.
15. Venkitachalam S, Chueh FY, Yu CL: Nuclear localization of lymphocyte-specific protein tyrosine kinase (Lck) and its role in regulating LIM domain only 2 (Lmo2) gene. Biochem Biophys Res Commun 2012;417:1058-1062.
16. Yao X, Balamurugan P, Arvey A, Leslie C, Zhang L: Heme controls the regulation of protein tyrosine kinases Jak2 and Src. Biochem Biophys Res Commun 2010;403:30-35.
17. Kurdi M, Booz GW: JAK redux: a second look at the regulation and role of JAKs in the heart. Am J Physiol Heart Circ Physiol 2009;297:H1545-H1556.
18. + exchange through Janus kinase 2 and calmodulin. J Biol Chem 2003;278:16908-16915. (Pubitemid 36799563)
19. Gatsios P, Terstegen L, Schliess F, Haussinger D, Kerr IM, Heinrich PC, Graeve L: Activation of the Janus kinase/signal transducer and activator of transcription pathway by osmotic shock. J Biol Chem 1998;273:22962-22968. (Pubitemid 28417472)
20. Hosseinzadeh Z, Shojaiefard M, Bhavsar SK, Lang F: Up-regulation of the betaine/GABA transporter BGT1 by JAK2. Biochem Biophys Res Commun 2012;420:172-177.
21. Handler JS, Kwon HM: Regulation of renal cell organic osmolyte transport by tonicity. Am J Physiol 1993;265:C1449-C1455.
22. Kempson SA, Montrose MH: Osmotic regulation of renal betaine transport: transcription and beyond. Pflugers Arch 2004;449:227-234. (Pubitemid 40064614)
23. Takenaka M, Preston AS, Kwon HM, Handler JS: The tonicity-sensitive element that mediates increased transcription of the betaine transporter gene in response to hypertonic stress. J Biol Chem 1994;269:29379-29381. (Pubitemid 24365079)
24. Huang Z, Tunnacliffe A: Response of human cells to desiccation: comparison with hyperosmotic stress response. J Physiol 2004;558:181-191. (Pubitemid 39077400)
25. Bitoun M, Tappaz M: Gene expression of the transporters and biosynthetic enzymes of the osmolytes in astrocyte primary cultures exposed to hyperosmotic conditions. Glia 2000;32:165-176.
26. Bitoun M, Tappaz M: Gene expression of taurine transporter and taurine biosynthetic enzymes in brain of rats with acute or chronic hyperosmotic plasma. A comparative study with gene expression of myo-inositol transporter, betaine transporter and sorbitol biosynthetic enzyme. Brain Res Mol Brain Res 2000;77:10-18. (Pubitemid 30256187)
27. - /betaine transporter mRNAs in individual cells of the kidney during changes in the diuretic state. Pflugers Arch 1999;437:248-254. (Pubitemid 29071965)
28. Denkert C, Warskulat U, Hensel F, Haussinger D: Osmolyte strategy in human monocytes and macrophages: involvement of p38MAPK in hyperosmotic induction of betaine and myoinositol transporters. Arch Biochem Biophys 1998;354:172-180. (Pubitemid 28372999)
29. +- myo-inositol cotransporter in rat brain. Am J Physiol 1996;271:F877-F885.
30. - inositol co-transporter. Nephrol Dial Transplant 1999;14:1217-1223. (Pubitemid 29209310)
31. Neuhofer W, Bartels H, Fraek ML, Beck FX: Relationship between intracellular ionic strength and expression of tonicity-responsive genes in rat papillary collecting duct cells. J Physiol 2002;543:147-153. (Pubitemid 34947302)
32. - inositol cotransporter mRNA in rat brain. Brain Res Mol Brain Res 1999;70:179-186. (Pubitemid 29317632)
33. Warskulat U, Brookmann S, Reinen A, Haussinger D: Ultraviolet B radiation induces cell shrinkage and increases osmolyte transporter mRNA expression and osmolyte uptake in HaCaT keratinocytes. Biol Chem 2007;388:1345-1352. (Pubitemid 350135566)
34. Warskulat U, Brookmann S, Felsner I, Brenden H, Grether-Beck S, Haussinger D: Ultraviolet A induces transport of compatible organic osmolytes in human dermal fibroblasts. Exp Dermatol 2008;17:1031-1036.
35. Wiese TJ, Dunlap JA, Conner CE, Grzybowski JA, Lowe WL, Jr., Yorek MA: Osmotic regulation of Namyo-inositol cotransporter mRNA level and activity in endothelial and neural cells. Am J Physiol 1996;270:C990-C997.
36. Yamauchi A, Nakanishi T, Takamitsu Y, Sugita M, Imai E, Noguchi T, Fujiwara Y, Kamada T, Ueda N: In vivo osmoregulation of Na/myo-inositol cotransporter mRNA in rat kidney medulla. J Am Soc Nephrol 1994;5:62-67. (Pubitemid 24977060)
37. - inositol cotransporter in rat kidney. J Clin Invest 1995;96:1195-1201.
38. - inositol transport is regulated by basolateral tonicity in Madin-Darby canine kidney cells. J Clin Invest 1996;97:263-267.
39. Zhang Z, Ferraris JD, Brooks HL, Brisc I, Burg MB: Expression of osmotic stress-related genes in tissues of normal and hyposmotic rats. Am J Physiol Renal Physiol 2003;285:F688-F693. (Pubitemid 37140252)
40. Arroyo JA, Garcia-Jones P, Graham A, Teng CC, Battaglia FC, Galan HL: Placental TonEBP/NFAT5 Osmolyte Regulation in an Ovine Model of Intrauterine Growth Restriction. Biol Reprod 2012;86:94.
41. Matskevitch J, Wagner CA, Risler T, Kwon HM, Handler JS, Waldegger S, Busch AE, Lang F: Effect of extracellular pH on the myo-inositol transporter SMIT expressed in Xenopus oocytes. Pflugers Arch 1998;436:854-857. (Pubitemid 28496730)
42. Feng J, Witthuhn BA, Matsuda T, Kohlhuber F, Kerr IM, Ihle JN: Activation of Jak2 catalytic activity requires phosphorylation of Y1007 in the kinase activation loop. Mol Cell Biol 1997;17:2497-2501. (Pubitemid 27175130)
43. Mohamed MR, Alesutan I, Foller M, Sopjani M, Bress A, Baur M, Salama RH, Bakr MS, Mohamed MA, Blin N, Lang F, Pfister M: Functional analysis of a novel I71N mutation in the GJB2 gene among Southern Egyptians causing autosomal recessive hearing loss. Cell Physiol Biochem 2010;26:959-966.
44. Eckey K, Strutz-Seebohm N, Katz G, Fuhrmann G, Henrion U, Pott L, Linke WA, Arad M, Lang F, Seebohm G: Modulation of human ether a gogo related channels by CASQ2 contributes to etiology of catecholaminergic polymorphic ventricular tachycardia (CPVT). Cell Physiol Biochem 2010;26:503-512.
45. Bohmer C, Sopjani M, Klaus F, Lindner R, Laufer J, Jeyaraj S, Lang F, Palmada M: The serum and glucocorticoid inducible kinases SGK1-3 stimulate the neutral amino acid transporter SLC6A19. Cell Physiol Biochem 2010;25:723-732.
46. Rexhepaj R, Dermaku-Sopjani M, Gehring EM, Sopjani M, Kempe DS, Foller M, Lang F: Stimulation of electrogenic glucose transport by glycogen synthase kinase 3. Cell Physiol Biochem 2010;26:641-646.
47. Dermaku-Sopjani M, Sopjani M, Saxena A, Shojaiefard M, Bogatikov E, Alesutan I, Eichenmuller M, Lang F: Downregulation of NaPi-IIa and NaPi-IIb Na-coupled phosphate transporters by coexpression of Klotho. Cell Physiol Biochem 2011;28:251-258.
48. Hosseinzadeh Z, Bhavsar SK, Sopjani M, Alesutan I, Saxena A, Dermaku-Sopjani M, Lang F: Regulation of the glutamate transporters by JAK2. Cell Physiol Biochem 2011;28:693-702.
49. Gong TW, Meyer DJ, Liao J, Hodge CL, Campbell GS, Wang X, Billestrup N, Carter-Su C, Schwartz J: Regulation of glucose transport and c-fos and egr-1 expression in cells with mutated or endogenous growth hormone receptors. Endocrinology 1998;139:1863-1871. (Pubitemid 28513847)
50. Yokota I, Hayashi H, Matsuda J, Saijo T, Naito E, Ito M, Ebina Y, Kuroda Y: Effect of growth hormone on the translocation of GLUT4 and its relation to insulin-like and anti-insulin action. Biochim Biophys Acta 1998;1404:451-456. (Pubitemid 28470546)
51. Hosseinzadeh Z, Bhavsar SK, Shojaiefard M, Saxena A, Merches K, Sopjani M, Alesutan I, Lang F: Stimulation of the glucose carrier SGLT1 by JAK2. Biochem Biophys Res Commun 2011;408:208-213.
52. Bhavsar SK, Hosseinzadeh Z, Merches K, Gu S, Broer S, Lang F: Stimulation of the amino acid transporter SLC6A19 by JAK2. Biochem Biophys Res Commun 2011;414:456-461.
53. Handler JS, Kwon HM: Regulation of the myo-inositol and betaine cotransporters by tonicity. Kidney Int 1996;49:1682-1683. (Pubitemid 26186598)
54. Hoffmann EK, Pedersen SF: Sensors and signal transduction pathways in vertebrate cell volume regulation. Contrib Nephrol 2006;152:54-104. (Pubitemid 44672103)
55. Pasantes-Morales H, Cruz-Rangel S: Brain volume regulation: osmolytes and aquaporin perspectives. Neuroscience 2010;168:871-884.
56. + exchanger in podocytes through a mechanism that involves Janus kinase and calmodulin. Biochim Biophys Acta 2009;1793:1174-1181.
57. Lang F, Busch GL, Ritter M, Volkl H, Waldegger S, Gulbins E, Haussinger D: Functional significance of cell volume regulatory mechanisms. Physiol Rev 1998;78:247-306. (Pubitemid 28070981)